تدريب Shadowing: Experience with the pEGASUS for rescue stenting and treatment of ICAD - تعلم التحدث بالإنجليزية مع YouTube

C2
So good afternoon everybody.
⏸ متوقف مؤقتاً
244 جمل
إذا كانت الجمل قصيرة أو طويلة جدًا، انقر على Edit لتعديلها.
1
So good afternoon everybody.
2
We will start with Wallaby Phenox Symposium.
3
We have the chance of having René Chapeau presenting the experience with Pegasus in the treatment of ICAD and rescue stenting.
4
So René, please.
5
Thank you, Laurent.
6
Let's go.
7
What to know about Pegasus?
8
It's a laser cut stand, open cell.
9
So if it's open cell,
10
it means that it opens properly in the curves.
11
That's an important interest.
12
and it can be placed through 0165 or 0117 microcasters,
13
which is of course very interesting too.
14
The official indications are indeed not only aneurysms,
15
but also dissection and stenosis,
16
and I report on our use in high cadence stroke.
17
Just to have an idea how the stent behaves in compared to the other ones,
18
first here, all the four are the Pegasus,
19
and you see that 45,
20
the diameter and length play a certain role in the radial force.
21
If you compare with Leo is more than a Leo,
22
it's a bit more than an Atlas also.
23
Of course, a wingspan is a bit more powerful.
24
So our experience about 40 patients,
25
most of them in acute stroke,
26
acute stroke divided in ICAD.
27
So obviously food plays a given role and food can be a reason for treatment of stroke where you see this here,
28
this tight stenosis responsible of the symptoms where PTA is being done
29
and after PTA the stent is delivered with its three markers distally and proximally we systematically oversize.
30
There is no reason not to do it because opening is good also So if you oversize,
31
here's a six months follow up.
32
Same thing, a bit more distally,
33
also this patient arrived with important symptoms and you can understand that he has symptoms because he has a stenosis,
34
obviously some more clot.
35
So we systematically put a stent weaver to try to remove and indeed it is better.
36
If you see this and this,
37
there's less material that you're supposed to push inside the perforators.
38
And then if you see that it's still not so good and you fear that it may occlude,
39
sometimes we wait and you see that it occludes or if we feel uncomfortable,
40
stand is being placed after PTA.
41
And here we are with the device
42
which is in place with approximate distance markers and the six months follow up where it remained more or less stable.
43
So this is enough of course.
44
technique.
45
Why to do PTA before?
46
Very simple reason.
47
The stent have a very low stability.
48
And if you just deploy it,
49
if you try to cross again,
50
a PTA balloon has not the same ability to navigate in the microcaster and the chance to displace it is there.
51
So better to PTA before.
52
Two patients, obviously it was not enough.
53
And here's another acutely decompensated intracranial stenosis, which is there.
54
I think it's very difficult to know the proper size.
55
And I'm always interested when I discuss with my colleagues from the US,
56
Ednan, Ricardo, and a lot of others that are very pro coronary balloons, balloon mounted stents.
57
I never know the proper size to give.
58
And if I don't know,
59
I think it's very safe to put a first PTA balloon to look how it is and potentially to increase them.
60
The price of these balloons is very low.
61
The navigability is amazing
62
and then we adapt to what we see here is the result also after six months very stable
63
and it works on the right side
64
and guess what on the left side too so here the left ica with a similar picture you see first First,
65
it came as acute stroke,
66
so stent tree was placed through.
67
And then we PTA increasingly,
68
two, two and a half.
69
This is the result just after it.
70
And just by placing the stent,
71
you see that you gain a lot more.
72
The zoom is not exactly the same,
73
but still you see that it's much better.
74
So there is an added value to put a mechanical factor.
75
So here, one solitaire, two PTAs with two and two and a half,
76
and then the four and a half Pegasus inside.
77
Some patients have rescue stenting when you try to do a lot and it does not work.
78
And this here is a 48-year-old man,
79
a high NIH score, with this LEM1 where it should be simple and easy.
80
And our preferential way to proceed here is to do dual stent reverse,
81
which usually works unless it does not.
82
So first pass did not work.
83
Second pass did not work.
84
Then change, Sophia Solitaire did not work.
85
Fourth pass, Mono Solitaire does not work.
86
Fifth pass, Double Solitaire.
87
Six pass, I mean, you wonder what to do when in a 90-year-old patient you would not continue at 48.
88
The point is when to do rescue stenting,
89
because you know it's going to be rescue stenting,
90
but honestly, I don't know.
91
And it's not so simple.
92
Seventh pass where Batu, who made the treatments,
93
decided to go on for a first stand.
94
And then he got access to the other branch,
95
put the second one in the Y connection,
96
and the result is still amazing.
97
And this is the CT on the next day,
98
and the MR six months later.
99
where everything's not perfect.
100
We found a major instant stenosis.
101
One of the stents is occluded,
102
the other one is major tight.
103
So we went back, did some instant PTA with drug eluting balloons in the distance,
104
smaller balloon, the proximal bit larger balloon.
105
And this is some few months later where you see that it's okay, it's good.
106
So definitely rescue stenting has a place,
107
but I think that defining is not so simple.
108
Dissection is also an interesting indication where I think there's no doubt
109
that the cause here for this patient to have a little distance stroke is this dissection with this here,
110
which is missing, where we put catch mini or time of catch mini here.
111
And then the Pegasus was placed.
112
This is immediately post.
113
This is, here are the markers.
114
Yes, the markers you see,
115
but you see them better when you have an arrow.
116
This is six months later,
117
where the hematoma is resolved and the vessels look good.
118
It's definitely the fact that here's a vessel which is angulated.
119
Makes sense to have something open cell, which is maximal flexible.
120
I mean, the other stands we have are good, too.
121
But the more the vessel has an important angulation,
122
I think the more it makes sense to go into the direction of open cell design.
123
No intraposital instant thrombosis, no distal vessel embolus that occurred.
124
Hemorrhagic complication that I'm going to show with this absolutely debatable treatment that was done by one of our colleagues.
125
I guess the clot must have been more proximal.
126
He still wanted to get it out.
127
Going distally, the stent river did not do the job.
128
And technically, it's absolutely no problem to go there with a micro catheter and deliver a stent river,
129
avoiding a stroke.
130
So that's the nice part.
131
But the price for this is to put anti-GP to be 3A.
132
And the consequence here, this is the end result.
133
And the consequence is next day,
134
a bleeding in a complete different territory.
135
But rescue stenting has a price,
136
and I think that there's a lot of enthusiasm to do rescue stenting.
137
I think it must be still very reasonable.
138
I don't think that this is here the best indication.
139
And this is one of the drawbacks.
140
even not in the territory where the stent was placed
141
but I think we we know need to know precisely how frequently this takes place.
142
Elective stenting and PTA okay this is a regular condition this is straight vessel
143
so any stent would have done the job including this one but looks good.
144
Reconstruction is something we're doing more and more in chronically occluded vessels or subacutely occluded
145
where indeed it's interesting to think when should be the moment when we recanalize the vessel.
146
Because acutely we've got a high risk of having clots that move.
147
If you do it later,
148
usually it's because some issues are occurring.
149
And this lady, she's 55,
150
she had six months earlier an acute stroke where you see that the siphon is there,
151
the character that its origin is occluded,
152
and she was treated by aspiration, partial treatment.
153
And then she got a braided stent, which is quite thrombogenic.
154
I'm not sure it's such a good idea to place this acutely,
155
which of course gives a good image.
156
But next day, stent was occluded.
157
Patient was not too bad.
158
It was lip like this.
159
And six months later, she came with ongoing TIAs this territory knowing
160
that the left ICA is occluded too and the left vert is occluded too.
161
So she only has the right vertebral artery.
162
What to do?
163
The problem is that she just has no right external carotid artery.
164
She just has the left ICA giving something at the siphon.
165
Everything's missing here.
166
And from the origin, you still have a stump,
167
which is indeed was quite helpful
168
because navigating here with a triple system 8f guiding 8f uh 5f
169
and then here terrible 35 allowed to go all through those
170
vessels without too much of efforts the difficulty is not here
171
the difficulty is once you get there to be able to re-enter
172
and even if you take a cto wire that punctures
173
when you're in a straight segment the chance to puncture outside is much higher than to puncture inside.
174
So here in fact what helped us was to take a
175
cheek eye wire where we could get access again to the lumen
176
and once it is done some PTA is being done
177
and then extensive stenting is done extracranially with two wall stents and we did the intracranial part with a very long Pegasus
178
and this is here the end result with two wall stands one protege
179
and one and one precise and one Pegasus in the end.
180
This is same situation where a lot is missing
181
and in the end this is here's a disease spot treated with the Pegasus and here's six months follow-up.
182
So as a conclusion we have the chance to have many self-explanable stands.
183
Self-explanable stands has advantage that when you have a nitri that varies in caliber, you can oversize.
184
And if the vessel is not straight,
185
open cell is of help.
186
Thank you.
187
Thank you.
188
Thank you very much, René ardan so there is a problem with 2b3a no question
189
but i think a better solution that is now available
190
is kangaroo lord you can actually load patients on kangaroo lord at a much lower dose than coronary dose
191
so you can actually even titrate what their pru is and
192
so that in theory it's still very early in theory should have a much lower risk profile than a 2B3A,
193
which I think is a big gun and really opens you up to all sorts of complications.
194
Probably it's a bit unfair to show this complication because we've got a lot of patients where we did not have bleeding.
195
So all the question of proportion and it seems to be still rare.
196
Interestingly, the literature in the mid 2010s was very negative against GP2B3A.
197
Now there's an important literature saying it's very good.
198
I think to see once in a while a complication enables you to remain grounded.
199
But potentially can go along.
200
Just one question.
201
And then, is that a good point what you say?
202
But does that mean that we can also do that,
203
for example, for thrombolic complication during aneurysm treatment?
204
Do you do that?
205
Do you replace Tirofiban or any GP2B3A by Congrelor,
206
or do you continue to use GP2B3A?
207
Two scenarios.
208
One is emergent stenting.
209
Emergent stenting for aneurysm, emergent stenting for ICAD.
210
I think that's where Congrelor is really good.
211
The second situation is instant thrombosis, okay, coiling-associate thrombosis.
212
I think in that instance to be 3a is definitely the standard
213
so there will still used to be 3a
214
But for emergent cases where you're loading the patient It's fast
215
and it's it's very useful so we have a different experience
216
so even for thromboembolic complications during the procedure the kangaroo law is working very well for us
217
so So we have completely switched to Cangrelor in last few months for everything.
218
In fact, we are sometimes placing intrasacular and flow diverters,
219
and if there's a clot formation,
220
we give Cangrelor on top of Ticagrelor or Presagrelor, whatever you're giving.
221
Yes, but we're switching here.
222
I mean, the focus was on stroke,
223
and I think that whatever medication you give in stroke,
224
It will be a question of rate because no doubt that cangrelar will also induce some leadings,
225
but nothing against cangrelar.
226
Rene, in the last case that you show, was patient blind?
227
No. Because it had the cavernous origin of the ophthalmic.
228
So yes, because the CTO and the wires did not go to the lumen here and just continued straight.
229
So we were concerned, and luckily she did not.
230
Thank you.
231
And one thing I observed,
232
René, is that in instant stenosis,
233
you use a drug eluding balloon.
234
Yes.
235
Yeah.
236
This is a practice that I have learned from here in Europe.
237
And I don't interact with any instant event without a drug eluding balloon.
238
Is this you do it for everyone?
239
It's extremely efficient.
240
I agree.
241
I agree.
242
Thank you very much, René.
243
Thank you.
244
Thank you, Laurent.

تنزيل التطبيق

تقييم بالذكاء الاصطناعي لكل جملة تنطقها

TRENDING

الأكثر شعبية

لماذا يجب ممارسة المحادثة باستخدام هذا الفيديو؟

يعد الفيديو المذكور مثالاً رائعاً لتعزيز ممارسة المحادثة الإنجليزية في سياق طبي. من خلال الاستماع إلى تجربة المتحدث، يمكن للمتعلمين تطوير مهاراتهم في التحدث وفهم المصطلحات المستخدمة في المجال الطبي. بالنظر إلى تفاصيل مثل استخدام جهاز Pegasus في علاج الشرايين، يمكن للمتعلمين توسيع مفرداتهم وتعزيز ثقتهم أثناء الحديث عن مواضيع متخصصة.

من الفوائد الأخرى لممارسة المحادثة مع هذا الفيديو هو التعرف على كيفية استخدام المصطلحات الفنية وكيفية توصيل المعلومات بشكل واضح ودقيق. التفاعل مع المحتوى المرئي يسهل على المتعلمين الاندماج في السرد، مما يحسن قدرتهم على التعبير الغير صوتي بالإضافة إلى تعبيرهم الصوتي.

القواعد والتعابير في السياق

يحتوي الفيديو على العديد من الهياكل اللغوية الهامة التي يمكن للمتعلمين استخدامها:

  • الجمل الوصفية: مثل "الاستعمال الرسمي يتضمن ليس فقط تمدد الأوعية الدموية، ولكن أيضاً التمزق والضيق". تساعد مثل هذه الجمل في تعلم كيفية وصف إجراءات معقدة بكلمات بسيطة.
  • الهياكل الشرطية: يتم استخدام هياكل مثل "إذا كنت تشعر بعدم الارتياح، يتم وضع الدعامة بعد PTA"، مما يفتح المجال لممارسة التعبير عن الشروط والنتائج.
  • التعبير عن التجربة: يستخدم المتحدث عبارات مثل "نجرب" و"نقوم بعملية" لتعزيز مفهوم الخبرة والتجريب عند مناقشة الإجراءات الطبية.

مصائد النطق الشائعة

تتضمن الفيديوات الطبية أحياناً كلمات قد تكون صعبة أو تحمل نطقاً غير مألوف. من الكلمات التي قد تشكل تحديات:

  • Pegasus: قد يكون نطقها صعباً على بعض المتعلمين بسبب تركيبتها الصوتية.
  • stenting: تمثل هذه الكلمة تحدياً في النطق، لذا يفضل تكرارها في سياقات مختلفة.
  • dissection و stenosis: هذه الكلمات الطبية تتطلب من المتعلمين التركيز على النطق الصحيح، خاصة عند استخدامها في جمل طويلة.

لمساعدتك في تحسين نطقك، يمكنك استخدام تقنيات مثل shadow speech المتاحة على shadowing site، مما يساعدك على تقليد المتحدثين وتحسين سرعة طلاقتك. استمتع بـ تعلم الإنجليزية مع يوتيوب والتطبيق العملي من خلال المشاهدة والتكرار!

ما هي تقنية التظليل الصوتي؟

التظليل الصوتي (Shadowing) تقنية تعلم لغة مدعومة علمياً، طُورت أصلاً لتدريب المترجمين الفوريين المحترفين. الطريقة بسيطة لكنها قوية: تستمع لصوت إنجليزي أصلي وتكرره فوراً بصوت عالٍ — كظل يتبع المتحدث بتأخير 1-2 ثانية. تُظهر الأبحاث تحسناً كبيراً في دقة النطق والتنغيم والإيقاع وربط الأصوات والاستماع والطلاقة.

اشترِ لنا قهوة